دورية أكاديمية

Understanding the Impact of Different Doses of Reducose® Mulberry Leaf Extract on Blood Glucose and Insulin Responses after Eating a Complex Meal: Results from a Double-Blind, Randomised, Crossover Trial

التفاصيل البيبلوغرافية
العنوان: Understanding the Impact of Different Doses of Reducose® Mulberry Leaf Extract on Blood Glucose and Insulin Responses after Eating a Complex Meal: Results from a Double-Blind, Randomised, Crossover Trial
المؤلفون: Pariyarath Sangeetha Thondre, Isabel Butler, Jonathan Tammam, Ifunanya Achebe, Elysia Young, Michael Lane, Andrew Gallagher
المصدر: Nutrients, Vol 16, Iss 11, p 1670 (2024)
بيانات النشر: MDPI AG, 2024.
سنة النشر: 2024
المجموعة: LCC:Nutrition. Foods and food supply
مصطلحات موضوعية: mulberry leaf extract, glycaemic response, insulinemic response, 1-deoxynojirimycin, Nutrition. Foods and food supply, TX341-641
الوصف: Non-communicable diseases (NCDs) are becoming an increasingly important health concern due to a rapidly ageing global population. The fastest growing NCD, type 2 diabetes mellitus (T2DM), is responsible for over 2 million deaths annually. Lifestyle changes, including dietary changes to low glycemic response (GR) foods, have been shown to reduce the risk of developing T2DM. The aim of this study was to investigate whether three different doses of Reducose®, a mulberry leaf extract, could lower the GR and insulinemic responses (IR) to a full meal challenge in healthy individuals. A double-blind, randomised, placebo-controlled, repeat-measure, crossover design trial was conducted by the Oxford Brookes Centre for Nutrition and Health; 37 healthy individuals completed the study. Participants consumed capsules containing either 200 mg, 225 mg, 250 mg Reducose® or placebo before a test meal consisting of 150 g white bread and egg mayo filler. Capillary blood samples were collected at 15-min intervals in the first hour and at 30-min intervals over the second and third hours to determine glucose and plasma insulin levels. The consumption of all three doses of Reducose® resulted in significantly lower blood glucose and plasma insulin levels compared to placebo. All three doses of Reducose® (200 mg, 225 mg, 250 mg) significantly lowered glucose iAUC 120 by 30% (p = 0.003), 33% (p = 0.001) and 32% (p = 0.002), respectively, compared with placebo. All three doses of Reducose® (200 mg, 225 mg, 250 mg) significantly lowered the plasma insulin iAUC 120 by 31% (p = 0.024), 34% (p = 0.004) and 38% (p < 0.001), respectively. The study demonstrates that the recommended dose (250 mg) and two lower doses (200 mg, 225 mg) of Reducose® can be used to help lower the GR and IR of a full meal containing carbohydrates, fats and proteins.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2072-6643
العلاقة: https://www.mdpi.com/2072-6643/16/11/1670Test; https://doaj.org/toc/2072-6643Test
DOI: 10.3390/nu16111670
الوصول الحر: https://doaj.org/article/166def04415446b1b7583b331e81e9eaTest
رقم الانضمام: edsdoj.166def04415446b1b7583b331e81e9ea
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20726643
DOI:10.3390/nu16111670